ZA964680B - Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection. - Google Patents
Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection.Info
- Publication number
- ZA964680B ZA964680B ZA9604680A ZA964680A ZA964680B ZA 964680 B ZA964680 B ZA 964680B ZA 9604680 A ZA9604680 A ZA 9604680A ZA 964680 A ZA964680 A ZA 964680A ZA 964680 B ZA964680 B ZA 964680B
- Authority
- ZA
- South Africa
- Prior art keywords
- feline immunodeficiency
- baculovirus
- virus infection
- use against
- vaccines produced
- Prior art date
Links
- 241000713800 Feline immunodeficiency virus Species 0.000 title 1
- 241000282324 Felis Species 0.000 title 1
- 206010061598 Immunodeficiency Diseases 0.000 title 1
- 208000029462 Immunodeficiency disease Diseases 0.000 title 1
- 230000007813 immunodeficiency Effects 0.000 title 1
- 241000701447 unidentified baculovirus Species 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 230000009385 viral infection Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/14011—Baculoviridae
- C12N2710/14111—Nucleopolyhedrovirus, e.g. autographa californica nucleopolyhedrovirus
- C12N2710/14141—Use of virus, viral particle or viral elements as a vector
- C12N2710/14143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/15011—Lentivirus, not HIV, e.g. FIV, SIV
- C12N2740/15022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/481,700 US5849303A (en) | 1995-06-07 | 1995-06-07 | Recombinant feline Immunodeficiency virus subunit vaccines employing baculoviral-expressed envelope glycoproteins derived from isolate NCSU-1 and their use against feline immunodeficiency virus infection |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA964680B true ZA964680B (en) | 1997-12-05 |
Family
ID=23913018
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA9604680A ZA964680B (en) | 1995-06-07 | 1996-06-05 | Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection. |
Country Status (6)
Country | Link |
---|---|
US (1) | US5849303A (xx) |
AR (1) | AR003135A1 (xx) |
AU (2) | AU6037396A (xx) |
CO (1) | CO4480039A1 (xx) |
WO (2) | WO1996040956A1 (xx) |
ZA (1) | ZA964680B (xx) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7087234B1 (en) | 1991-07-09 | 2006-08-08 | Cornell Research Foundation, Inc. | Recombinant multivalent viral vaccine |
FR2775601B1 (fr) | 1998-03-03 | 2001-09-21 | Merial Sas | Vaccins vivants recombines et adjuves |
US8541003B2 (en) | 2003-06-20 | 2013-09-24 | Protein Sciences Corporation | Vectors expressing SARS immunogens, compositions containing such vectors or expression products thereof, methods and assays for making and using |
CA2537429A1 (en) * | 2003-09-11 | 2005-03-24 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
ATE434763T1 (de) * | 2003-12-18 | 2009-07-15 | Idexx Lab Inc | Verfahren zum nachweis des felinen immunschwächevirus |
ATE504834T1 (de) * | 2004-02-19 | 2011-04-15 | Idexx Lab Inc | Verfahren und vorrichtung zum nachweis von katzen-immunschwächevirus |
JP4662988B2 (ja) * | 2004-06-30 | 2011-03-30 | アイデックス ラボラトリーズ インコーポレイテッド | ネコ免疫不全ウイルスを検出するための方法および装置 |
EP1761556A1 (en) * | 2004-06-30 | 2007-03-14 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus (fiv) comprising the use of peptides derived from the v3 region of the fiv env protein |
CA2576902C (en) * | 2004-06-30 | 2012-05-08 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
US7291338B2 (en) * | 2005-03-09 | 2007-11-06 | Idexx Laboratories, Inc. | Method and device for detecting feline immunodeficiency virus |
US20070135826A1 (en) | 2005-12-01 | 2007-06-14 | Steve Zaver | Method and apparatus for delivering an implant without bias to a left atrial appendage |
JOP20190083A1 (ar) | 2008-06-04 | 2017-06-16 | Amgen Inc | بولي ببتيدات اندماجية طافرة لـfgf21 واستخداماتها |
TWI560197B (en) | 2009-05-05 | 2016-12-01 | Amgen Inc | Fgf21 mutants and uses thereof |
EP2553452B1 (en) | 2010-04-02 | 2015-03-04 | IDEXX Laboratories, Inc. | Detection of feline immunodeficiency virus |
WO2015077717A1 (en) | 2013-11-25 | 2015-05-28 | The Broad Institute Inc. | Compositions and methods for diagnosing, evaluating and treating cancer by means of the dna methylation status |
WO2015085147A1 (en) | 2013-12-05 | 2015-06-11 | The Broad Institute Inc. | Polymorphic gene typing and somatic change detection using sequencing data |
JP7060324B2 (ja) | 2013-12-20 | 2022-04-26 | ザ・ブロード・インスティテュート・インコーポレイテッド | ネオ抗原ワクチンによる併用療法 |
WO2016100975A1 (en) | 2014-12-19 | 2016-06-23 | Massachsetts Institute Ot Technology | Molecular biomarkers for cancer immunotherapy |
EP3234130B1 (en) | 2014-12-19 | 2020-11-25 | The Broad Institute, Inc. | Methods for profiling the t-cell- receptor repertoire |
CR20200476A (es) | 2015-05-20 | 2020-12-02 | Dana Farber Cancer Inst Inc | ANTÍGENOS COMPARTIDOS (Divisional 2017-0584) |
TWI750122B (zh) | 2015-06-09 | 2021-12-21 | 美商博德研究所有限公司 | 用於贅瘤疫苗之調配物及其製備方法 |
US20190346442A1 (en) | 2016-04-18 | 2019-11-14 | The Broad Institute, Inc. | Improved hla epitope prediction |
EP3574116A1 (en) | 2017-01-24 | 2019-12-04 | The Broad Institute, Inc. | Compositions and methods for detecting a mutant variant of a polynucleotide |
US20210382068A1 (en) | 2018-10-02 | 2021-12-09 | Dana-Farber Cancer Institute, Inc. | Hla single allele lines |
WO2020131586A2 (en) | 2018-12-17 | 2020-06-25 | The Broad Institute, Inc. | Methods for identifying neoantigens |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2669338A1 (fr) * | 1990-11-21 | 1992-05-22 | Centre Nat Rech Scient | Fragments peptidiques issus de la proteine externe du vif, anticorps antifragments, application de ceux-ci au diagnostic et/ou au traitement de l'immunodeficience feline. |
CA2111325C (en) * | 1991-06-14 | 2007-10-23 | Bruce Ernest Kemp | Detection of mammalian immunodeficiency viruses |
GB9215233D0 (en) * | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
GB9215232D0 (en) * | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
GB9219936D0 (en) * | 1992-09-21 | 1992-11-04 | Pitman Moore Inc | Vaccines |
FR2700957B1 (fr) * | 1993-01-29 | 1995-03-03 | Seppic Sa | Composition de vaccin sous-unitaire recombinant vivant et procédé de préparation. |
JPH09512177A (ja) * | 1994-04-29 | 1997-12-09 | ファルマシア・アンド・アップジョン・カンパニー | ネコ免疫不全ウイルスワクチン |
FR2721031B1 (fr) * | 1994-06-09 | 1996-07-26 | Centre Nat Rech Scient | Fragment peptidique spécifique du virus de l'immunodéficience féline (VIF) et son utilisation comme réactif de diagnostic. |
-
1995
- 1995-06-07 US US08/481,700 patent/US5849303A/en not_active Expired - Fee Related
-
1996
- 1996-06-03 AU AU60373/96A patent/AU6037396A/en not_active Abandoned
- 1996-06-03 WO PCT/US1996/008640 patent/WO1996040956A1/en active Application Filing
- 1996-06-05 ZA ZA9604680A patent/ZA964680B/xx unknown
- 1996-06-05 AR ARP960102964A patent/AR003135A1/es unknown
- 1996-06-06 AU AU60937/96A patent/AU6093796A/en not_active Abandoned
- 1996-06-06 WO PCT/US1996/009224 patent/WO1996040957A1/en active Application Filing
- 1996-06-06 CO CO96029447A patent/CO4480039A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU6037396A (en) | 1996-12-30 |
US5849303A (en) | 1998-12-15 |
CO4480039A1 (es) | 1997-07-09 |
AU6093796A (en) | 1996-12-30 |
AR003135A1 (es) | 1998-07-08 |
WO1996040956A1 (en) | 1996-12-19 |
WO1996040957A1 (en) | 1996-12-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA964680B (en) | Recombinant feline immunodeficiency vaccines produced in baculovirus and their use against feline immunodeficiency virus infection. | |
ZA964694B (en) | Recombinant raccoon pox viruses and their use as an effective vaccine against feline immunodeficiency virus infection. | |
ZA975889B (en) | HIV envelope polypeptides and vaccine. | |
HUP9802217A3 (en) | Recombinant mva virus, and the use thereof | |
BR9400651A (pt) | Compósito absorvente, e peça de vestuário absorvente descartável | |
EP0597008A4 (en) | Improved expression of influenza a m2 protein in baculovirus and uses of m2 protein. | |
IL112860A0 (en) | Recombinant viruses their preparation and their therapeutic uses | |
AU2328397A (en) | Recombinant live feline immunodeficiency virus and proviral dna vaccines | |
AU8918998A (en) | Non-immunosuppressive cyclosporins and their use in the prevention and treatmentof hiv infection | |
EP0467700A3 (en) | Coconjugate vaccines comprising immunogenic protein, hiv related peptides, and anionic moieties | |
ZA9610721B (en) | Grapevine leafroll virus proteins and their uses. | |
AU4556597A (en) | Recombinant mva virus expressing dengue virus antigens, and the use thereof in vaccines | |
ZA936592B (en) | Nutrition for persons infected with human immunodeficiency virus | |
EP0569862A3 (en) | Self-adhesive medical sheet and medical preparation. | |
ZA986421B (en) | 2-[Pyrazolyl-and triazolyl-3'-oxymethylene]phenylisoxa zolones, -triazolones and - tetrazolones, their preparation and their use. | |
EP0631506A4 (en) | VACCINES COMPRISING SELECTIVELY DEGLYCOSYLATED HUMAN IMMUNODEFICIENCY VIRUS ENVELOPE PROTEINS. | |
ZA964679B (en) | Genetically altered feline immunodeficiency viruses and their use as an effective vaccine against feline immunodeficiency virus infection. | |
HU9503802D0 (en) | Optically active benzothiepin derivative, its preparation and use | |
CZ2000522A3 (cs) | Farmaceutický prostředek na bázi piperidinalkanolového antihistaminika a použití | |
IL112075A0 (en) | Recombinant human thymopoietin proteins, their preparation and their medicinal use | |
EP0868196A4 (en) | SYNTHETIC VACCINE TO PROTECT AGAINST INFECTION BY THE HUMANE IMMUNDEFIZIENZ VIRUS | |
ZA969402B (en) | Novel oligopeptides, the preparation and use thereof. | |
AU1825895A (en) | Retroviral vaccines, vaccination and immune-therapy for retroviral infections | |
AU2946395A (en) | Recombinant infectious laryngotracheitis virus and vaccine | |
ZA9610510B (en) | Novel peptides, the preparation and use thereof. |